glp-1 eyesight Receptor Agonists and vision risk GLP-1 Vision Loss MDL Grows
Description
Curr Diabetes Rev 13(3):315321 Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR et al (2019) Glucagon-like peptide 1 (GLP-1)
Anti-obesity drug discovery: Advances and challenges
Ozempic is not a weight-loss drug
During clinical trials, 30% of adults and 22% of adolescents reported diarrhea while taking Wegovy injection
Getting refills can be a little more complicated, since the process may differ from a traditional pharmacy
But the increase in sweetness was pretty similar across all three medications
